Improvements in Algorithms for Phenotype Inference: The NAT2 Example

E-ISSN： 1875-5453|15|2|233-249

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.2, 2014-02, pp. : 233-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

By Donald P. Parkin D. Seifart H. Schaaf H. Helden P. Werely C. Sirgel F. Venter A. Maritz J.

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 633-639

Springer Publishing Company

Access to resources Recommend Favorite

A four-SNP NAT2 genotyping panel recommended to infer human acetylator phenotype

By Hein David W Doll Mark A

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 855-855

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphism in N-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity

By Walker Katy

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 440-472

Taylor & Francis Ltd

Access to resources Recommend Favorite

NAT2 sequence polymorphisms and acetylation profiles in Indians

By Khan Naazneen Pande Veena Das Aparup

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 289-303

Future Medicine

Access to resources Recommend Favorite

Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine

By Farker Katrin Schotte Uwe Scheele Johannes Hoffmann Annemarie

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 387-391

Urban & Fischer

Access to resources Recommend Favorite